(Q37798463)

English

Bringing natural products into the fold - exploring the therapeutic lead potential of secondary metabolites for the treatment of protein-misfolding-related neurodegenerative diseases

scientific article published on 07 October 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Bringing natural products into the fold - exploring the therapeutic lead potential of secondary metabolites for the treatment of protein-misfolding-related neurodegenerative diseases (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

protein folding

0 references

neurodegeneration

1 reference

based on heuristic

inferred from title

natural product

1 reference

based on heuristic

inferred from title

secondary metabolite

1 reference

based on heuristic

inferred from title

Robert H Cichewicz

2

object named as

Robert H Cichewicz

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

author name string

P Matthew Joyner

1

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

publication date

7 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Natural Product Reports

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

26-47

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Inflammation in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Common mechanisms of amyloid oligomer pathogenesis in degenerative disease

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

An update on pharmacological approaches to neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

The role of natural product chemistry in drug discovery

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Natural products as leads to potential drugs: an old process or the new hope for drug discovery?

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Natural products as sources of new drugs over the last 25 years

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Galanthamine from snowdrop--the development of a modern drug against Alzheimer's disease from local Caucasian knowledge

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Natural products and derivatives affecting neurotransmission relevant to Alzheimer's and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Plants with neurobiological activity as potential targets for drug discovery.

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

New anti-Alzheimer drugs from biodiversity: the role of the natural acetylcholinesterase inhibitors

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Acetylcholinesterase inhibition by flavonoids from Agrimonia pilosa.

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Natural products and their derivatives as cholinesterase inhibitors in the treatment of neurodegenerative disorders: an update

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Contemporary anticholinesterase pharmaceuticals of natural origin and their synthetic analogues for the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Search for natural products related to regeneration of the neuronal network.

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Neuroprotective effects of natural products: interaction with intracellular kinases, amyloid peptides and a possible role for transthyretin

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Role of nitric oxide synthases in Parkinson's disease: a review on the antioxidant and anti-inflammatory activity of polyphenols

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Neuroinflammation and its modulation by flavonoids

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Molecular and biochemical features in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Parkinson's disease

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Research in motion: the enigma of Parkinson's disease pathology spread

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Disease-modifying drugs and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Novel pharmacological targets for the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Functional models of Parkinson's disease: a valuable tool in the development of novel therapies

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

The 6-hydroxydopamine model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Drug Insight: new drugs in development for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Behavioral recovery following sub-chronic paeoniflorin administration in the striatal 6-OHDA lesion rodent model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

In vivo modulation of dopaminergic nigrostriatal pathways by cytisine derivatives: implications for Parkinson's Disease

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

A new neuroprotective compound of Ligustrum japonicum leaves

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Anti-apoptotic effect of esculin on dopamine-induced cytotoxicity in the human neuroblastoma SH-SY5Y cell line

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Huntington's disease: from pathology and genetics to potential therapies

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Huntington's disease

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Small molecule drug discovery for Huntington's Disease

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Glycogen synthase kinase-3beta facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Glycogen synthase kinase-3beta inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Glycogen synthase kinase-3 (GSK-3) inhibitory activity and structure-activity relationship (SAR) studies of the manzamine alkaloids. Potential for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

New manzamine alkaloids with potent activity against infectious diseases

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Structure-activity relationship and mechanism of action studies of manzamine analogues for the control of neuroinflammation and cerebral infections.

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Apoptotic cascades as possible targets for inhibiting cell death in Huntington's disease

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Discorhabdin P, a new enzyme inhibitor from a deep-water Caribbean sponge of the genus Batzella

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

The ubiquitin proteasome system in Huntington's disease and the spinocerebellar ataxias

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Role of autophagy in the clearance of mutant huntingtin: a step towards therapy?

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Pathophysiology of Huntington's disease: from huntingtin functions to potential treatments

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Recent advances in the chemistry, biosynthesis and pharmacology of rapamycin analogs

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

FKBP family proteins: immunophilins with versatile biological functions

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin.

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Rapamycin alleviates toxicity of different aggregate-prone proteins

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Reversal of a full-length mutant huntingtin neuronal cell phenotype by chemical inhibitors of polyglutamine-mediated aggregation

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Calcineurin inhibitors cause an acceleration of the neurological phenotype in a mouse transgenic for the human Huntington's disease mutation

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Genetic and pharmacological inhibition of calcineurin corrects the BDNF transport defect in Huntington's disease

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Resveratrol: a natural compound with pharmacological potential in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease.

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Cytotoxicity of a mutant huntingtin fragment in yeast involves early alterations in mitochondrial OXPHOS complexes II and III.

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons.

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Bioactivity profiling with parallel mass spectrometry reveals an assemblage of green tea metabolites affording protection against human huntingtin and alpha-synuclein toxicity

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Understanding the natural variability of prion diseases

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Mechanisms of prion protein aggregation

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Amphotericin B.

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Amphotericin B inhibits the generation of the scrapie isoform of the prion protein in infected cultures.

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Nonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity.

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Cannabidiol: a promising drug for neurodegenerative disorders?

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Inhibition of Protease-Resistant Prion Protein Accumulation In Vitro by Curcumin

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Clinical potential of minocycline for neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Minocycline and neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Minocycline as a neuroprotective agent

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Pharmacological intervention at ionotropic glutamate receptor complexes.

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Neuroimmunophilin ligands: the development of novel neuroregenerative/ neuroprotective compounds

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Advances in small molecules promoting neurotrophic function

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Microglial activation and its implications in the brain diseases.

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Anti-inflammatory drugs in the treatment of neurodegenerative diseases: current state

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Multifunctional neuroprotective drugs targeting monoamine oxidase inhibition, iron chelation, adenosine receptors, and cholinergic and glutamatergic action for neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Inhibitory effect of fangchinoline on excitatory amino acids-induced neurotoxicity in cultured rat cerebellar granule cells

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Four new neuroprotective iridoid glycosides from Scrophularia buergeriana roots

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Four new neuroprotective dihydropyranocoumarins from Angelica gigas

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Neuroprotective limonoids of root bark of Dictamnus dasycarpus

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Cynandione A from Cynanchum wilfordii protects cultured cortical neurons from toxicity induced by H2O2, L-glutamate, and kainate

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Carquinostatin B, a new neuronal cell-protecting substance produced by Streptomyces exfoliatus

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Therapeutic potential of neurotrophic factors for neurological disorders

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Small molecule activators of the Trk receptors for neuroprotection

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Stem cell-based cell therapy in neurological diseases: a review

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Activity of macrocyclic jatrophane diterpenes from Euphorbia kansui in a TrkA fibroblast survival assay

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Axon- or dendrite-predominant outgrowth induced by constituents from Ashwagandha.

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

(-)-3,5-Dicaffeoyl-muco-quinic acid isolated from Aster scaber contributes to the differentiation of PC12 cells: through tyrosine kinase cascade signaling

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Proteasome inhibition by fellutamide B induces nerve growth factor synthesis

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Role of Nrf2 and p62/ZIP in the neurite outgrowth by carnosic acid in PC12h cells

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Panaxadiol glycosides that induce neuronal differentiation in neurosphere stem cells

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Axonal and dendritic extension by protopanaxadiol-type saponins from ginseng drugs in SK-N-SH cells

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Neurotrophic activity of honokiol on the cultures of fetal rat cortical neurons

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by a Coptidis Rhizoma extract and protoberberine alkaloids

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Farinosones A-C, neurotrophic alkaloidal metabolites from the entomogenous deuteromycete Paecilomyces farinosus

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Nardosinone, a novel enhancer of nerve growth factor in neurite outgrowth from PC12D cells

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Total synthesis as a resource in drug discovery: the first in vivo evaluation of panaxytriol and its derivatives

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Novel tetramic acids and pyridone alkaloids, militarinones B, C, and D, from the insect pathogenic fungus Paecilomyces militaris

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

(+)-N-Deoxymilitarinone A, a neuritogenic pyridone alkaloid from the insect pathogenic fungus Paecilomyces farinosus

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Sphingolipids from Bombycis Corpus 101A and their neurotrophic effects

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Stimulation of neurotrophic factor secretion from 1321N1 human astrocytoma cells by novel diterpenoids, scabronines A and G.

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Potentiation of nerve growth factor-induced elongation of neurites by gelsemiol and 9-hydroxysemperoside aglucone in PC12D cells

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Neurodegeneration in models of Gram-positive bacterial infections of the central nervous system

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Transcriptional regulation of iNOS and COX-2 by a novel compound from Curcuma comosa in lipopolysaccharide-induced microglial activation

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Antiparasitic, antineuroinflammatory, and cytotoxic polyketides from the marine sponge Plakortis angulospiculatus collected in Brazil.

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

15,16-dihydrotanshinone I suppresses the activation of BV-2 cell, a murine microglia cell line, by lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Alkaloids from the leaves of Uncaria rhynchophylla and their inhibitory activity on NO production in lipopolysaccharide-activated microglia

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

6-Hydroxycleroda-3,13-dien-15,16-olide protects neuronal cells from lipopolysaccharide-induced neurotoxicity through the inhibition of microglia-mediated inflammation

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Inhibition of inducible NO synthase, cyclooxygenase-2 and interleukin-1beta by torilin is mediated by mitogen-activated protein kinases in microglial BV2 cells

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Differential modulation of microglia superoxide anion and thromboxane B2 generation by the marine manzamines

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Mitochondria in neurodegenerative disorders: regulation of the redox state and death signaling leading to neuronal death and survival

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Human monoamine oxidase enzyme inhibition by coffee and beta-carbolines norharman and harman isolated from coffee

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Xanthones from Gentianella amarella ssp. acuta with acetylcholinesterase and monoamine oxidase inhibitory activities

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

1-methyl-2-undecyl-4(1H)-quinolone as an irreversible and selective inhibitor of type B monoamine oxidase

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Inhibitory activity of monoamine oxidase by coumarins from Peucedanum japonicum

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Inhibition of type A monoamine oxidase by coptisine in mouse brain

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Natural Products as a Source of CNS-Active Agents

1 reference

https://api.crossref.org/works/10.1039%2FC0NP00017E

21 January 2018

Ueber die Bestandteile der Wurzel von Baptisia tinctoria

1 reference

9 March 2024

https://opencitations.net/index/api/v1/citations/10.1002/ARDP.18972350502

A novel neuronal cell protecting substance, aestivophoenin C, produced by Streptomyces purpeofuscus.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.51.880

A novel neuronal cell protecting substance, espicufolin, produced by Streptomyces sp. cu39

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.49.947

Formobactin, a Novel Free Radical Scavenging and Neuronal Cell Protecting Substance from Nocardia sp.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.49.839

Isolation and structure elucidation of novel neuronal cell protecting substances, carbazomadurins A and B produced by Actinomadura madurae

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.50.770

Novel neuronal cell protecting substances, aestivophoenins A and B, produced by Streptomyces purpeofuscus

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.48.1378

Phenazostatin C, a new diphenazine with neuronal cell protecting activity from Streptomyces sp

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.52.758

Benzastatins A, B, C, and D: new free radical scavengers from Streptomyces nitrosporeus 30643. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.49.20

A novel neuronal cell protecting substance, naphthomycinol, produced by Streptomyces sp. PF7

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.49.1172

Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.28.727

A New Neuronal Cell Protecting Substance, Lavanduquinocin, Produced by Streptomyces viridochromogenes

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.48.574

Monoamine oxidase inhibitory naphthoquinone and/or naphthalene dimers from Lemuni Hitam (Diospyros sp.), a Malaysian herbal medicine

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.47.1473

Monoamine Oxidase Inhibitory Constituents from Anixiella micropertusa.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.46.1506

Phenolic constituents of licorice. III. Structures of glicoricone and licofuranone, and inhibitory effects of licorice constituents on monoamine oxidase

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.39.1238

Trigonelline-induced neurite outgrowth in human neuroblastoma SK-N-SH cells

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/BPB.22.679

Identifiers

10.1039/C0NP00017E

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37798463&oldid=2246481317"